Sort
15,273 grants matching “antimicrobial resistance”
Molecular pathogenesis of Blastomycosis
$494,393Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2015 · AI
Molecular pathogenesis of Blastomycosis
$494,393Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2019 · AI
Disrupting Biofilm Formation to Improve TB Drug Treatment
$494,344Randall J Basaraba · Colorado State University · R01 · FY2016 · AI
ANti-infective Stewardship using the Wisca tool in the Electronic medical Record
$494,290Lance Robert Peterson · Endeavor Health Clinical Operations · R01 · FY2015 · HS
ANti-infective Stewardship using the Wisca tool in the Electronic medical Record
$494,289Lance Robert Peterson · Endeavor Health Clinical Operations · R01 · FY2016 · HS
The matrix of Pseudomonas aeruginosa biofilms
$494,196Daniel J Wozniak · Wake Forest University Health Sciences · R01 · FY2008 · AI
Antibiotic Potentiation by Targeting of a Signal Transduction System
$494,175Robert S. Daum · University Of Chicago · R33 · FY2017 · AI
Characterizing the ImPact of COVID-19 on Antibiotic PreScribing in AcutE Care and IDentifying Resilient Stewardship Strategies (POISED)
$494,077Michael Santino Pulia · University Of Wisconsin-Madison · R01 · FY2022 · HS
Role of MUC1 in the host defense against urinary tract infection
$494,045Mohammad Al-Bataineh · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogen
$493,958Tor C. Savidge · University Of Texas Hlth Sci Ctr Houston · P01 · FY2020 · AI
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosa
$493,942Matthew R. Parsek · University Of Washington · R01 · FY2012 · AI
Molecular Basis of Host Parasite Interaction
$493,811Justin Sonnenburg · Stanford University · T32 · FY2025 · AI
Transforming Translational Science and Education to Benefit Human Health
$493,737Barry Coller · Rockefeller University · UL1 · FY2011 · RR
Oxidative Burst in Influenza and MRSA Co-infection
$493,658Keer Sun · University Of Nebraska Medical Center · R01 · FY2019 · HL
Oxidative Burst in Influenza and MRSA Co-infection
$493,658Keer Sun · University Of Nebraska Medical Center · R01 · FY2020 · HL
De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children
$493,639Jason Newland · Washington University · R01 · FY2019 · HS
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
$493,630Barbara Wells Trautner · Baylor College Of Medicine · R01 · FY2020 · HS
Disrupting Biofilm Formation to Improve TB Drug Treatment
$493,620Randall J Basaraba · Colorado State University · R01 · FY2015 · AI
Survival of Neisseria gonorrhoeae after primary human neutrophil challenge
$493,565Alison K Criss · University Of Virginia · R01 · FY2019 · AI
Divergence of Phagocytic and Antimicrobial Programs in Leprosy
$493,365Robert L Modlin · University Of California Los Angeles · R01 · FY2011 · AI
Xylitol syrup for the prevention of acute otitis media in otitis-prone children
$493,196Louis Vernacchio · Boston Children'S Hospital · RC1 · FY2009 · DC
Divergence of Phagocytic and Antimicrobial Programs in Leprosy
$493,167Robert L Modlin · University Of California Los Angeles · R01 · FY2012 · AI
Divergence of Phagocytic and Antimicrobial Programs in Leprosy
$493,167Robert L Modlin · University Of California Los Angeles · R01 · FY2014 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$493,126Patrick S. Stayton · University Of Washington · R01 · FY2018 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$493,087Patrick S. Stayton · University Of Washington · R01 · FY2019 · AI